Membrane estrogen receptor-α contributes to female protection against high-fat diet-induced metabolic disorders
BackgroundEstrogen Receptor α (ERα) is a significant modulator of energy balance and lipid/glucose metabolisms. Beyond the classical nuclear actions of the receptor, rapid activation of intracellular signaling pathways is mediated by a sub-fraction of ERα localized to the plasma membrane, known as M...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-07-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2023.1215947/full |
_version_ | 1797777970464555008 |
---|---|
author | Aurélie Fabre Blandine Tramunt Blandine Tramunt Alexandra Montagner Céline Mouly Elodie Riant Marie-Lou Calmy Marine Adlanmerini Coralie Fontaine Rémy Burcelin Françoise Lenfant Jean-François Arnal Pierre Gourdy Pierre Gourdy |
author_facet | Aurélie Fabre Blandine Tramunt Blandine Tramunt Alexandra Montagner Céline Mouly Elodie Riant Marie-Lou Calmy Marine Adlanmerini Coralie Fontaine Rémy Burcelin Françoise Lenfant Jean-François Arnal Pierre Gourdy Pierre Gourdy |
author_sort | Aurélie Fabre |
collection | DOAJ |
description | BackgroundEstrogen Receptor α (ERα) is a significant modulator of energy balance and lipid/glucose metabolisms. Beyond the classical nuclear actions of the receptor, rapid activation of intracellular signaling pathways is mediated by a sub-fraction of ERα localized to the plasma membrane, known as Membrane Initiated Steroid Signaling (MISS). However, whether membrane ERα is involved in the protective metabolic actions of endogenous estrogens in conditions of nutritional challenge, and thus contributes to sex differences in the susceptibility to metabolic diseases, remains to be clarified.MethodsMale and female C451A-ERα mice, harboring a point mutation which results in the abolition of membrane localization and MISS-related effects of the receptor, and their wild-type littermates (WT-ERα) were maintained on a normal chow diet (NCD) or fed a high-fat diet (HFD). Body weight gain, body composition and glucose tolerance were monitored. Insulin sensitivity and energy balance regulation were further investigated in HFD-fed female mice.ResultsC451A-ERα genotype had no influence on body weight gain, adipose tissue accumulation and glucose tolerance in NCD-fed mice of both sexes followed up to 7 months of age, nor male mice fed a HFD for 12 weeks. In contrast, compared to WT-ERα littermates, HFD-fed C451A-ERα female mice exhibited: 1) accelerated fat mass accumulation, liver steatosis and impaired glucose tolerance; 2) whole-body insulin resistance, assessed by hyperinsulinemic-euglycemic clamps, and altered insulin-induced signaling in skeletal muscle and liver; 3) significant decrease in energy expenditure associated with histological and functional abnormalities of brown adipose tissue and a defect in thermogenesis regulation in response to cold exposure.ConclusionBesides the well-characterized role of ERα nuclear actions, membrane-initiated ERα extra-nuclear signaling contributes to female, but not to male, protection against HFD-induced obesity and associated metabolic disorders in mouse. |
first_indexed | 2024-03-12T23:11:36Z |
format | Article |
id | doaj.art-7890cae83ba44e8a8594da44db58b761 |
institution | Directory Open Access Journal |
issn | 1664-2392 |
language | English |
last_indexed | 2024-03-12T23:11:36Z |
publishDate | 2023-07-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Endocrinology |
spelling | doaj.art-7890cae83ba44e8a8594da44db58b7612023-07-18T01:39:15ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922023-07-011410.3389/fendo.2023.12159471215947Membrane estrogen receptor-α contributes to female protection against high-fat diet-induced metabolic disordersAurélie Fabre0Blandine Tramunt1Blandine Tramunt2Alexandra Montagner3Céline Mouly4Elodie Riant5Marie-Lou Calmy6Marine Adlanmerini7Coralie Fontaine8Rémy Burcelin9Françoise Lenfant10Jean-François Arnal11Pierre Gourdy12Pierre Gourdy13Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Institut National de la Santé et de la Recherche Médicale (INSERM)/Université Paul Sabatier (UPS), Université Toulouse 3, Toulouse, FranceInstitut des Maladies Métaboliques et Cardiovasculaires (I2MC), Institut National de la Santé et de la Recherche Médicale (INSERM)/Université Paul Sabatier (UPS), Université Toulouse 3, Toulouse, FranceService de Diabétologie, Maladies Métaboliques et Nutrition, Centre Hospitalier Universitaire (CHU) de Toulouse, Toulouse, FranceInstitut des Maladies Métaboliques et Cardiovasculaires (I2MC), Institut National de la Santé et de la Recherche Médicale (INSERM)/Université Paul Sabatier (UPS), Université Toulouse 3, Toulouse, FranceService d’Endocrinologie et Nutrition, Centre Hospitalier Universitaire (CHU) de Toulouse, Toulouse, FranceInstitut des Maladies Métaboliques et Cardiovasculaires (I2MC), Institut National de la Santé et de la Recherche Médicale (INSERM)/Université Paul Sabatier (UPS), Université Toulouse 3, Toulouse, FranceInstitut des Maladies Métaboliques et Cardiovasculaires (I2MC), Institut National de la Santé et de la Recherche Médicale (INSERM)/Université Paul Sabatier (UPS), Université Toulouse 3, Toulouse, FranceInstitut des Maladies Métaboliques et Cardiovasculaires (I2MC), Institut National de la Santé et de la Recherche Médicale (INSERM)/Université Paul Sabatier (UPS), Université Toulouse 3, Toulouse, FranceInstitut des Maladies Métaboliques et Cardiovasculaires (I2MC), Institut National de la Santé et de la Recherche Médicale (INSERM)/Université Paul Sabatier (UPS), Université Toulouse 3, Toulouse, FranceInstitut des Maladies Métaboliques et Cardiovasculaires (I2MC), Institut National de la Santé et de la Recherche Médicale (INSERM)/Université Paul Sabatier (UPS), Université Toulouse 3, Toulouse, FranceInstitut des Maladies Métaboliques et Cardiovasculaires (I2MC), Institut National de la Santé et de la Recherche Médicale (INSERM)/Université Paul Sabatier (UPS), Université Toulouse 3, Toulouse, FranceInstitut des Maladies Métaboliques et Cardiovasculaires (I2MC), Institut National de la Santé et de la Recherche Médicale (INSERM)/Université Paul Sabatier (UPS), Université Toulouse 3, Toulouse, FranceInstitut des Maladies Métaboliques et Cardiovasculaires (I2MC), Institut National de la Santé et de la Recherche Médicale (INSERM)/Université Paul Sabatier (UPS), Université Toulouse 3, Toulouse, FranceService de Diabétologie, Maladies Métaboliques et Nutrition, Centre Hospitalier Universitaire (CHU) de Toulouse, Toulouse, FranceBackgroundEstrogen Receptor α (ERα) is a significant modulator of energy balance and lipid/glucose metabolisms. Beyond the classical nuclear actions of the receptor, rapid activation of intracellular signaling pathways is mediated by a sub-fraction of ERα localized to the plasma membrane, known as Membrane Initiated Steroid Signaling (MISS). However, whether membrane ERα is involved in the protective metabolic actions of endogenous estrogens in conditions of nutritional challenge, and thus contributes to sex differences in the susceptibility to metabolic diseases, remains to be clarified.MethodsMale and female C451A-ERα mice, harboring a point mutation which results in the abolition of membrane localization and MISS-related effects of the receptor, and their wild-type littermates (WT-ERα) were maintained on a normal chow diet (NCD) or fed a high-fat diet (HFD). Body weight gain, body composition and glucose tolerance were monitored. Insulin sensitivity and energy balance regulation were further investigated in HFD-fed female mice.ResultsC451A-ERα genotype had no influence on body weight gain, adipose tissue accumulation and glucose tolerance in NCD-fed mice of both sexes followed up to 7 months of age, nor male mice fed a HFD for 12 weeks. In contrast, compared to WT-ERα littermates, HFD-fed C451A-ERα female mice exhibited: 1) accelerated fat mass accumulation, liver steatosis and impaired glucose tolerance; 2) whole-body insulin resistance, assessed by hyperinsulinemic-euglycemic clamps, and altered insulin-induced signaling in skeletal muscle and liver; 3) significant decrease in energy expenditure associated with histological and functional abnormalities of brown adipose tissue and a defect in thermogenesis regulation in response to cold exposure.ConclusionBesides the well-characterized role of ERα nuclear actions, membrane-initiated ERα extra-nuclear signaling contributes to female, but not to male, protection against HFD-induced obesity and associated metabolic disorders in mouse.https://www.frontiersin.org/articles/10.3389/fendo.2023.1215947/fullsex differencesestrogen receptor alpha (ERα)membrane-initiated steroid signalingobesityinsulin resistancethermogenesis |
spellingShingle | Aurélie Fabre Blandine Tramunt Blandine Tramunt Alexandra Montagner Céline Mouly Elodie Riant Marie-Lou Calmy Marine Adlanmerini Coralie Fontaine Rémy Burcelin Françoise Lenfant Jean-François Arnal Pierre Gourdy Pierre Gourdy Membrane estrogen receptor-α contributes to female protection against high-fat diet-induced metabolic disorders Frontiers in Endocrinology sex differences estrogen receptor alpha (ERα) membrane-initiated steroid signaling obesity insulin resistance thermogenesis |
title | Membrane estrogen receptor-α contributes to female protection against high-fat diet-induced metabolic disorders |
title_full | Membrane estrogen receptor-α contributes to female protection against high-fat diet-induced metabolic disorders |
title_fullStr | Membrane estrogen receptor-α contributes to female protection against high-fat diet-induced metabolic disorders |
title_full_unstemmed | Membrane estrogen receptor-α contributes to female protection against high-fat diet-induced metabolic disorders |
title_short | Membrane estrogen receptor-α contributes to female protection against high-fat diet-induced metabolic disorders |
title_sort | membrane estrogen receptor α contributes to female protection against high fat diet induced metabolic disorders |
topic | sex differences estrogen receptor alpha (ERα) membrane-initiated steroid signaling obesity insulin resistance thermogenesis |
url | https://www.frontiersin.org/articles/10.3389/fendo.2023.1215947/full |
work_keys_str_mv | AT aureliefabre membraneestrogenreceptoracontributestofemaleprotectionagainsthighfatdietinducedmetabolicdisorders AT blandinetramunt membraneestrogenreceptoracontributestofemaleprotectionagainsthighfatdietinducedmetabolicdisorders AT blandinetramunt membraneestrogenreceptoracontributestofemaleprotectionagainsthighfatdietinducedmetabolicdisorders AT alexandramontagner membraneestrogenreceptoracontributestofemaleprotectionagainsthighfatdietinducedmetabolicdisorders AT celinemouly membraneestrogenreceptoracontributestofemaleprotectionagainsthighfatdietinducedmetabolicdisorders AT elodieriant membraneestrogenreceptoracontributestofemaleprotectionagainsthighfatdietinducedmetabolicdisorders AT marieloucalmy membraneestrogenreceptoracontributestofemaleprotectionagainsthighfatdietinducedmetabolicdisorders AT marineadlanmerini membraneestrogenreceptoracontributestofemaleprotectionagainsthighfatdietinducedmetabolicdisorders AT coraliefontaine membraneestrogenreceptoracontributestofemaleprotectionagainsthighfatdietinducedmetabolicdisorders AT remyburcelin membraneestrogenreceptoracontributestofemaleprotectionagainsthighfatdietinducedmetabolicdisorders AT francoiselenfant membraneestrogenreceptoracontributestofemaleprotectionagainsthighfatdietinducedmetabolicdisorders AT jeanfrancoisarnal membraneestrogenreceptoracontributestofemaleprotectionagainsthighfatdietinducedmetabolicdisorders AT pierregourdy membraneestrogenreceptoracontributestofemaleprotectionagainsthighfatdietinducedmetabolicdisorders AT pierregourdy membraneestrogenreceptoracontributestofemaleprotectionagainsthighfatdietinducedmetabolicdisorders |